0001968202-23-000011.txt : 20230503
0001968202-23-000011.hdr.sgml : 20230503
20230503160117
ACCESSION NUMBER: 0001968202-23-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230503
DATE AS OF CHANGE: 20230503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RYAN ARTHUR F
CENTRAL INDEX KEY: 0001187443
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 23883550
MAIL ADDRESS:
STREET 1: CITIZENS FINANCIAL GROUP, INC
STREET 2: 600 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0407
4
2023-05-01
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001187443
RYAN ARTHUR F
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
1
Common Stock
2023-05-01
4
S
0
16
802.67
D
19031
D
Common Stock
2023-05-01
4
S
0
30
803.58
D
19001
D
Common Stock
2023-05-01
4
S
0
2
804.51
D
18999
D
Common Stock
2023-05-01
4
S
0
5
805.34
D
18994
D
Common Stock
2023-05-01
4
S
0
15
806.53
D
18979
D
Common Stock
2023-05-01
4
S
0
17
807.5
D
18962
D
Common Stock
2023-05-01
4
S
0
15
808.11
D
18947
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 4, 2022.
Represents volume-weighted average price of sales of 16 shares of Company stock on May 1, 2023 at prices ranging from $802.57 to $802.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 30 shares of Company stock on May 1, 2023 at prices ranging from $803.22 to $803.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 2 shares of Company stock on May 1, 2023 at prices ranging from $804.20 to $804.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 5 shares of Company stock on May 1, 2023 at prices ranging from $805.22 to $805.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 15 shares of Company stock on May 1, 2023 at prices ranging from $806.01 to $806.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 17 shares of Company stock on May 1, 2023 at prices ranging from $807.12 to $807.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 15 shares of Company stock on May 1, 2023 at prices ranging from $808.00 to $808.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
/s/**Arthur F. Ryan
2023-05-03